Paper
0
Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial
Authors
Viola Poeschel,Gerhard Held
Marita Ziepert,Mathias Witzens‐Harig,Harald Holte,Lorenz Thurner,Peter Borchmann,Andreas Viardot,Martin Soekler,Ulrich Keller,Christian Schmidt,Lorenz Truemper,Rolf Mahlberg,Reinhard Marks,Heinz‐Gert Hoeffkes,Bernd Metzner,Judith Dierlamm,Norbert Frickhofen,Mathias Haenel,Andreas Neubauer,Michael Kneba,Francesco Merli,Alessandra Tucci,Peter Brown,Massimo Federico,Eva Lengfelder,Alice Rocco,Ralf Trappe,Andreas Rosenwald,Christian Berdel,Martin Maisenhoelder,Ofer Shpilberg,Josif Amam,Konstantinos Christofyllakis,Frank Hartmann,Niels Murawski,Stephan Stilgenbauer,Maike Nickelsen,Gerald Wulf,Bertram Glaß,Norbert Schmitz,Bettina Altmann,Markus Loeffler,Michael Pfreundschuh
+42 authors
,Ulrich JägerJournal
Published
Dec 1, 2019
Show more
Save
Tip0
TipSave